17 results
8-K
EX-10.1
NKGN
NKGen Biotech Inc
11 Apr 24
NKGen Biotech Secures Additional Financing of $5 Million to Continue Advancing Its Clinical Programs
8:05am
of any use, generation, manufacture, storage, disposal, release or threatened release of a hazardous waste or substance on the Collateral … such investigations, studies, samplings and testings as may be requested by the Lender or any governmental authority relative to any substance, or any waste
424B3
8c3 8i40wainki
14 Aug 23
Prospectus supplement
4:30pm
S-4/A
pv1szxim20f3whayo5
26 Jun 23
Registration of securities issued in business combination transactions (amended)
5:02pm
S-4
vhipxfu6ipap1p4
15 May 23
Registration of securities issued in business combination transactions
3:02pm
425
EX-2.1
j12v1wfpt1zl54jys
17 Apr 23
Business combination disclosure
6:02am
8-K
EX-2.1
whpuy41
17 Apr 23
Entry into a Material Definitive Agreement
6:01am
- Prev
- 1
- Next